Brief: Brii Biosciences Announces Agreements With Qpex And Disposal Of Equity Interests In Qpex
26/06/2023 02:24
June 26 (Reuters) - Brii Biosciences Ltd 2137.HK :
* DEFINITIVE AGREEMENTS WITH QPEX AND- DISPOSAL OF EQUITY
INTERESTS IN QPEX
* WILL ACQUIRE EXCLUSIVE GLOBAL RIGHTS FOR DEVELOPMENT AND
COMMERCIALIZATION OF BRII-693 FROM QPEX
* COMPANY WILL RETURN TO QPEX EXCLUSIVE RIGHTS TO
QPX7728-BASED
PRODUCTS
* QPEX WILL PAY COMPANY US$8 MILLION
* CO WILL DISPOSE ALL EQUITY INTERESTS IN QPEX IT HELD AND
RECEIVE
APPROXIMATELY US$16 MILLION UPON CLOSING
Further company coverage: 2137.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brii Biosciences
See all newsBrief: BRII Biosciences Discloses Launch Of BRISC, An SIRNA Therapeutics Discovery Platform
China's Brii Biosciences interim net loss narrows on lower R&D expenses
Brief: Brii Biosciences Announces Share Buy-Back Programme No More Than HK$60 Million
Brief: Brii Biosciences Says Arbitration Between Brii And Vir Remains In Early Stages With No Resolution
Brief: Brii Biosciences Submits Demand For Arbitration Against VIR